اعلان شركة المجتمع الرائدة الطبية عن تعيين عضو في المقعد الشاغر بمجلس الإدارة

Almujtama Alraida Medical Co. Announces the appointment of a member to fill the vacant seat on the Board of Directors. 9592 ALMUJTAMA MEDICAL 0.00 % 1447/06/04     25/11/2025 15:59:14 Introduction Almujtama Alraida Medical Co. announces that the Board of Directors issued a decision on November 25, 2025 (by circulation) to appoint Mr. Hamad Hamdan Saree Al-Sourayia (Independent) as a member of the Board of Directors in the vacant seat on its Board of Directors. Appointed Member Name Hamad Hamdan Al-Sourayia Membership Type Independent Membership Start Date 2025-11-25 Corresponding to 1447-06-04 Brief Resume of the Appointed Member He currently serves as CEO of the United Mining Industries Company, one of the world's largest gypsum companies, a listed Saudi joint-stock company. He also holds the position of member and representative of the Yanbu Chamber in the Council of Chambers and has contributed to the development of the gypsum industry and the expansion of the company's activities with the latest modern technologies in the mining industries. He previously served as General Manager of Red Sea Cables Company and remains a member of its Board of Directors. He also serves on the boards of Al-Sourayia Flooring and Furnishings Company and United Insulation Company. He holds a Master's degree in Business Administration and Finance from Brock University in Canada and a Bachelor's degree in Accounting from King Abdulaziz University. The date of the approval by other official authorities Not applicable Date of Board Meeting in which Appointed New Member(s) were Appointed 2025-11-25 Corresponding to 1447-06-04 Board Approval Board Approval May not be Deemed Final, this Appointment Shall Be Put before the First General Assembly Meeting for Approval The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. Share